NZ586025A - Rasagiline mesylate tablet coated with a composisiton comprising methacrylic acid - ethyl acrylate copolymer and triethyl citrate - Google Patents
Rasagiline mesylate tablet coated with a composisiton comprising methacrylic acid - ethyl acrylate copolymer and triethyl citrateInfo
- Publication number
- NZ586025A NZ586025A NZ586025A NZ58602509A NZ586025A NZ 586025 A NZ586025 A NZ 586025A NZ 586025 A NZ586025 A NZ 586025A NZ 58602509 A NZ58602509 A NZ 58602509A NZ 586025 A NZ586025 A NZ 586025A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ethyl acrylate
- acrylate copolymer
- methacrylic acid
- tablet
- rasagiline mesylate
- Prior art date
Links
- 229920001577 copolymer Polymers 0.000 title abstract 3
- JDBJJCWRXSVHOQ-UTONKHPSSA-N methanesulfonic acid;(1r)-n-prop-2-ynyl-2,3-dihydro-1h-inden-1-amine Chemical compound CS(O)(=O)=O.C1=CC=C2[C@H](NCC#C)CCC2=C1 JDBJJCWRXSVHOQ-UTONKHPSSA-N 0.000 title abstract 3
- 229960001956 rasagiline mesylate Drugs 0.000 title abstract 3
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 title abstract 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 title abstract 2
- 235000013769 triethyl citrate Nutrition 0.000 title abstract 2
- 239000001069 triethyl citrate Substances 0.000 title abstract 2
- 239000011248 coating agent Substances 0.000 abstract 3
- 238000000576 coating method Methods 0.000 abstract 3
- 239000004014 plasticizer Substances 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000008055 phosphate buffer solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1086008P | 2008-01-11 | 2008-01-11 | |
| PCT/US2009/000134 WO2009089049A1 (en) | 2008-01-11 | 2009-01-09 | Rasagiline formulations, their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ586025A true NZ586025A (en) | 2012-08-31 |
Family
ID=40850833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ586025A NZ586025A (en) | 2008-01-11 | 2009-01-09 | Rasagiline mesylate tablet coated with a composisiton comprising methacrylic acid - ethyl acrylate copolymer and triethyl citrate |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090181086A1 (https=) |
| EP (1) | EP2234478A4 (https=) |
| JP (2) | JP5583597B2 (https=) |
| KR (1) | KR20100107028A (https=) |
| CN (1) | CN101909438A (https=) |
| AU (1) | AU2009204454B2 (https=) |
| BR (1) | BRPI0905680A2 (https=) |
| CA (1) | CA2711817A1 (https=) |
| EA (1) | EA201070842A1 (https=) |
| IL (1) | IL206136A0 (https=) |
| MX (1) | MX2010007601A (https=) |
| NZ (1) | NZ586025A (https=) |
| SG (1) | SG187455A1 (https=) |
| WO (1) | WO2009089049A1 (https=) |
| ZA (1) | ZA201004086B (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006014973A2 (en) * | 2004-07-26 | 2006-02-09 | Teva Pharmaceutical Industries, Ltd. | Pharmaceutical dosage forms including rasagiline |
| US20090111892A1 (en) * | 2004-11-24 | 2009-04-30 | Shulamit Patashnik | Rasagiline Orally Disintegrating Compositions |
| WO2006091657A1 (en) * | 2005-02-23 | 2006-08-31 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations of improved content uniformity |
| ES2551481T3 (es) * | 2006-02-21 | 2015-11-19 | Teva Pharmaceutical Industries, Ltd. | Uso de rasagilina para el tratamiento de atrofia multisistémica |
| JP5769923B2 (ja) * | 2006-04-03 | 2015-08-26 | テバ ファーマシューティカル インダストリーズ リミティド | レストレスレッグス症候群の治療のためのラサギリンの使用 |
| EP1892233A1 (de) | 2006-08-18 | 2008-02-27 | Ratiopharm GmbH | Neue Salze des Wirkstoffs Rasagilin |
| CN101557706B (zh) * | 2006-12-14 | 2013-08-07 | 泰华制药工业有限公司 | 雷沙吉兰碱结晶固体 |
| EP1987816A1 (de) * | 2007-04-30 | 2008-11-05 | Ratiopharm GmbH | Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff |
| CA2698695A1 (en) * | 2007-09-05 | 2009-03-12 | Teva Pharmaceutical Industries Ltd. | Method of treating glaucoma using rasagiline |
| US8188149B2 (en) * | 2007-09-17 | 2012-05-29 | Teva Pharmaceutical Industries, Ltd. | Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss |
| WO2009151594A1 (en) * | 2008-06-10 | 2009-12-17 | Teva Pharmaceutical Industries, Ltd. | Rasagiline soft gelatin capsules |
| MX2010013766A (es) * | 2008-06-13 | 2011-03-15 | Teva Pharmaceutical Ind Ltd Star | Rasagilina para modificacion de enfermedad de parkinson. |
| BRPI0909997A2 (pt) | 2008-06-19 | 2015-10-27 | Teva Pharma | r(+)-n-propargil-1-aminoindano cristalino, composição farmacêutica, processo de secagem de r(+)-n-propargil-1-aminoindano sólido, processo de preparação de uma composição farmacêutica, processo de produção de um lote validado de um produto de farmaco que contém r(+)-n-propargil-1-aminoindano cristalino e pelo menos um veículo farmaceuticamente aceitável para distribuição e processo de prudução de r(+)-n-propargil-1-aminoindano cristalino |
| US8334409B2 (en) * | 2008-06-19 | 2012-12-18 | Teva Pharmaceutical Industries, Ltd. | Process for purifying rasagiline base |
| US20100189791A1 (en) * | 2009-01-23 | 2010-07-29 | Teva Pharmaceutical Industries, Ltd. | Delayed release rasagiline malate formulation |
| SI2451771T1 (sl) | 2009-07-09 | 2014-10-30 | Ratiopharm Gmbh | Soli rasagilina in njihovi farmacevtski pripravki |
| EP2515891A4 (en) * | 2009-12-22 | 2013-06-05 | Teva Pharma | 3-keto-N-propargyl-1-aminoindan |
| JP2013537530A (ja) | 2010-07-27 | 2013-10-03 | テバ ファーマシューティカル インダストリーズ リミティド | ラサギリンシトレートの分散物 |
| AU2011282720B2 (en) | 2010-07-27 | 2016-12-22 | Teva Pharmaceutical Industries Ltd. | Use of rasagiline for the treatment of olfactory dysfunction |
| HK1200315A1 (en) | 2011-10-10 | 2015-08-07 | Teva Pharmaceutical Industries Ltd. | R(+)-n-formyl-propargyl-aminoindan |
| JP2014534197A (ja) | 2011-10-10 | 2014-12-18 | テバ ファーマシューティカル インダストリーズ リミティド | Ｒ（＋）−ｎ−メチル−プロパルギルアミノインダン |
| JP2015529196A (ja) | 2012-08-17 | 2015-10-05 | テバ ファーマシューティカル インダストリーズ リミティド | ラサギリンの非経口製剤 |
| EP4615444A1 (en) * | 2022-11-07 | 2025-09-17 | Natural Medtech Pty Ltd | Tryptamine formulations and uses thereof |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL92952A (en) * | 1990-01-03 | 1994-06-24 | Teva Pharma | R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them |
| US5744500A (en) * | 1990-01-03 | 1998-04-28 | Teva Pharmaceutical Industries, Ltd. | Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
| IL99759A (en) * | 1991-10-16 | 1997-06-10 | Teva Pharma | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them |
| DK0707475T3 (da) * | 1993-06-14 | 1997-12-29 | Janssen Pharmaceutica Nv | Langsom frigørende, filmcoatet tablet af astemizol og pseudoephedrin |
| IL115357A (en) * | 1995-09-20 | 2000-01-31 | Teva Pharma | Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols |
| IL118836A (en) * | 1996-07-11 | 2001-01-11 | Teva Pharma | Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan |
| ES2241064T3 (es) * | 1996-12-18 | 2005-10-16 | Teva Pharmaceutical Industries, Ltd. | Derivados de aminoindano. |
| ES2432117T3 (es) * | 2002-11-15 | 2013-11-29 | Teva Pharmaceutical Industries Limited | Uso de rasagilina con riluzol para tratar la esclerosis lateral amiotrófica |
| US20050220864A1 (en) * | 2004-04-02 | 2005-10-06 | Chien-Hsuan Han | Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist |
| WO2006014973A2 (en) * | 2004-07-26 | 2006-02-09 | Teva Pharmaceutical Industries, Ltd. | Pharmaceutical dosage forms including rasagiline |
| AU2005266882A1 (en) * | 2004-07-26 | 2006-02-02 | Teva Pharmaceutical Indudstries, Ltd. | Dosage forms with an enterically coated core tablet |
| US20090111892A1 (en) * | 2004-11-24 | 2009-04-30 | Shulamit Patashnik | Rasagiline Orally Disintegrating Compositions |
| WO2006091657A1 (en) * | 2005-02-23 | 2006-08-31 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations of improved content uniformity |
| US7572834B1 (en) * | 2005-12-06 | 2009-08-11 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations and processes for their preparation |
| ES2551481T3 (es) * | 2006-02-21 | 2015-11-19 | Teva Pharmaceutical Industries, Ltd. | Uso de rasagilina para el tratamiento de atrofia multisistémica |
| EP1892233A1 (de) * | 2006-08-18 | 2008-02-27 | Ratiopharm GmbH | Neue Salze des Wirkstoffs Rasagilin |
| CN101557706B (zh) * | 2006-12-14 | 2013-08-07 | 泰华制药工业有限公司 | 雷沙吉兰碱结晶固体 |
| EP1987816A1 (de) * | 2007-04-30 | 2008-11-05 | Ratiopharm GmbH | Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff |
| CA2698695A1 (en) * | 2007-09-05 | 2009-03-12 | Teva Pharmaceutical Industries Ltd. | Method of treating glaucoma using rasagiline |
| US8188149B2 (en) * | 2007-09-17 | 2012-05-29 | Teva Pharmaceutical Industries, Ltd. | Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss |
| WO2009151594A1 (en) * | 2008-06-10 | 2009-12-17 | Teva Pharmaceutical Industries, Ltd. | Rasagiline soft gelatin capsules |
| MX2010013766A (es) * | 2008-06-13 | 2011-03-15 | Teva Pharmaceutical Ind Ltd Star | Rasagilina para modificacion de enfermedad de parkinson. |
| US8334409B2 (en) * | 2008-06-19 | 2012-12-18 | Teva Pharmaceutical Industries, Ltd. | Process for purifying rasagiline base |
| BRPI0909997A2 (pt) * | 2008-06-19 | 2015-10-27 | Teva Pharma | r(+)-n-propargil-1-aminoindano cristalino, composição farmacêutica, processo de secagem de r(+)-n-propargil-1-aminoindano sólido, processo de preparação de uma composição farmacêutica, processo de produção de um lote validado de um produto de farmaco que contém r(+)-n-propargil-1-aminoindano cristalino e pelo menos um veículo farmaceuticamente aceitável para distribuição e processo de prudução de r(+)-n-propargil-1-aminoindano cristalino |
| EA201170181A1 (ru) * | 2008-07-11 | 2011-08-30 | Синтон Бв | Полиморфные формы разагилина гидрохлорида |
| US20100029987A1 (en) * | 2008-07-29 | 2010-02-04 | Dipharma Francis S.R.I. | Crystalline Form of Rasagiline and Process for the Preparation Thereof |
| DE102008064061A1 (de) * | 2008-12-19 | 2010-06-24 | Ratiopharm Gmbh | Feste Zusammensetzung mit dem Wirkstoff Rasagilin |
| US20100189791A1 (en) * | 2009-01-23 | 2010-07-29 | Teva Pharmaceutical Industries, Ltd. | Delayed release rasagiline malate formulation |
| AU2010304755A1 (en) * | 2009-10-09 | 2012-05-24 | Teva Pharmaceutical Industries, Ltd. | Use of rasagiline for the treatment of Progressive Supranuclear Palsy |
| EP2515891A4 (en) * | 2009-12-22 | 2013-06-05 | Teva Pharma | 3-keto-N-propargyl-1-aminoindan |
| AU2011282720B2 (en) * | 2010-07-27 | 2016-12-22 | Teva Pharmaceutical Industries Ltd. | Use of rasagiline for the treatment of olfactory dysfunction |
| JP2013537530A (ja) * | 2010-07-27 | 2013-10-03 | テバ ファーマシューティカル インダストリーズ リミティド | ラサギリンシトレートの分散物 |
| SG189454A1 (en) * | 2010-10-26 | 2013-05-31 | Teva Pharma | Deuterium enriched rasagiline |
| HK1200315A1 (en) * | 2011-10-10 | 2015-08-07 | Teva Pharmaceutical Industries Ltd. | R(+)-n-formyl-propargyl-aminoindan |
| JP2014534197A (ja) * | 2011-10-10 | 2014-12-18 | テバ ファーマシューティカル インダストリーズ リミティド | Ｒ（＋）−ｎ−メチル−プロパルギルアミノインダン |
| AU2012323346A1 (en) * | 2011-10-10 | 2014-05-15 | Teva Pharmaceutical Industries Ltd | Rasagiline citramide |
-
2009
- 2009-01-09 EP EP20090700388 patent/EP2234478A4/en not_active Withdrawn
- 2009-01-09 CN CN2009801017416A patent/CN101909438A/zh active Pending
- 2009-01-09 EA EA201070842A patent/EA201070842A1/ru unknown
- 2009-01-09 KR KR1020107016952A patent/KR20100107028A/ko not_active Ceased
- 2009-01-09 SG SG2013002241A patent/SG187455A1/en unknown
- 2009-01-09 MX MX2010007601A patent/MX2010007601A/es not_active Application Discontinuation
- 2009-01-09 BR BRPI0905680-7A patent/BRPI0905680A2/pt not_active IP Right Cessation
- 2009-01-09 JP JP2010542277A patent/JP5583597B2/ja not_active Expired - Fee Related
- 2009-01-09 AU AU2009204454A patent/AU2009204454B2/en not_active Ceased
- 2009-01-09 NZ NZ586025A patent/NZ586025A/xx unknown
- 2009-01-09 CA CA2711817A patent/CA2711817A1/en not_active Abandoned
- 2009-01-09 WO PCT/US2009/000134 patent/WO2009089049A1/en not_active Ceased
- 2009-01-09 US US12/319,576 patent/US20090181086A1/en not_active Abandoned
-
2010
- 2010-06-02 IL IL206136A patent/IL206136A0/en unknown
- 2010-06-08 ZA ZA2010/04086A patent/ZA201004086B/en unknown
-
2014
- 2014-07-16 JP JP2014146160A patent/JP2014237668A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100107028A (ko) | 2010-10-04 |
| EA201070842A1 (ru) | 2011-04-29 |
| JP2014237668A (ja) | 2014-12-18 |
| EP2234478A1 (en) | 2010-10-06 |
| US20090181086A1 (en) | 2009-07-16 |
| AU2009204454B2 (en) | 2015-02-05 |
| AU2009204454A1 (en) | 2009-07-16 |
| MX2010007601A (es) | 2010-08-03 |
| JP5583597B2 (ja) | 2014-09-03 |
| SG187455A1 (en) | 2013-02-28 |
| WO2009089049A1 (en) | 2009-07-16 |
| CA2711817A1 (en) | 2009-07-16 |
| JP2011509295A (ja) | 2011-03-24 |
| EP2234478A4 (en) | 2013-01-23 |
| CN101909438A (zh) | 2010-12-08 |
| BRPI0905680A2 (pt) | 2015-07-07 |
| ZA201004086B (en) | 2011-08-31 |
| IL206136A0 (en) | 2010-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ586025A (en) | Rasagiline mesylate tablet coated with a composisiton comprising methacrylic acid - ethyl acrylate copolymer and triethyl citrate | |
| JP2011509295A5 (https=) | ||
| JP2017128614A5 (https=) | ||
| JP2020023518A5 (https=) | ||
| JP2014506321A5 (https=) | ||
| NZ589445A (en) | Rasagiline for parkinson's disease modification | |
| AR075148A1 (es) | Formulacion de rasagilina de liberacion retardada. proceso para fabricar citrato de rasagilina | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| NZ620879A (en) | A novel formulation of indomethacin | |
| NZ620887A (en) | A novel formulation of diclofenac | |
| WO2011107855A3 (en) | Sustained release oral liquid suspension dosage form | |
| WO2009017838A3 (en) | Combinations of jak-2 inhibitors and other agents | |
| NZ598534A (en) | Dosage regimen of an s1p receptor modulator | |
| JP2009143964A5 (https=) | ||
| NZ593467A (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| WO2009090670A3 (en) | Stabilized sustained release composition of bupropion hydrochloride and process for preparing the same | |
| JP2013507352A5 (https=) | ||
| RU2010107843A (ru) | Бупропиона гидробромид и его терапевтические применения | |
| JP2014534197A5 (https=) | ||
| JP2013502446A5 (https=) | ||
| NZ600583A (en) | Visfatin therapeutic agents for the treatment of acne and other conditions | |
| JP2020513032A5 (https=) | ||
| RU2015140572A (ru) | Способы лечения колоректального рака | |
| JP2015517994A5 (https=) | ||
| JP2012502103A5 (https=) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 09 JAN 2016 BY DENNEMEYER SA Effective date: 20130308 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 09 JAN 2019 BY DENNEMEYER + CO Effective date: 20140828 Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 09 JAN 2029 BY DENNEMEYER + CO Effective date: 20140828 Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 09 JAN 2022 BY DENNEMYER + CO Effective date: 20140828 |